探索药物治疗在心理健康中的意义:聚焦大麻。

IF 2 Q3 PHARMACOLOGY & PHARMACY
Pharmacy Pub Date : 2024-06-27 DOI:10.3390/pharmacy12040100
Claudete da Costa-Oliveira, Michele Lafayette Pereira, Nicole Ferrari de Carvalho, Luiza Aparecida Luna Silvério, Ygor Jessé Ramos, Priscila Gava Mazzola
{"title":"探索药物治疗在心理健康中的意义:聚焦大麻。","authors":"Claudete da Costa-Oliveira, Michele Lafayette Pereira, Nicole Ferrari de Carvalho, Luiza Aparecida Luna Silvério, Ygor Jessé Ramos, Priscila Gava Mazzola","doi":"10.3390/pharmacy12040100","DOIUrl":null,"url":null,"abstract":"<p><p>Although preliminary evidence suggests <i>Cannabis</i>'s efficacy in symptom control for anxiety and depression-psychiatric disorders that significantly impact mental health-much remains to be understood about its effects on the central nervous system (CNS) and how to optimize treatment for these disorders. This study aims to conduct a narrative review to evaluate pharmaceutical care in treating symptoms of anxiety and depression alongside <i>Cannabis</i> use, focusing on safety and therapeutic efficacy optimization. We seek to conceptualize anxiety and depression disorders, review evidence on <i>Cannabis</i> use, evaluate the evidence quality, and identify knowledge gaps. Twelve articles were identified, revealing a significant gap in the literature regarding the integration of pharmaceutical care with <i>Cannabis</i>-based therapies, specifically for anxiety and depression. Despite a growing interest in the relationship between <i>Cannabis</i> and mental health, current research is insufficient for a comprehensive understanding. The relationship between <i>Cannabis</i> use and anxiety and depression disorders requires further, more targeted investigations. This study underscores the importance of future research to fill existing gaps, providing informed insights and robust guidelines for the safe and effective use of <i>Cannabis</i> as part of the treatment for anxiety and depression. It is crucial that pharmaceutical care integrates these therapies responsibly to improve the overall well-being of patients.</p>","PeriodicalId":30544,"journal":{"name":"Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270281/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on <i>Cannabis</i>.\",\"authors\":\"Claudete da Costa-Oliveira, Michele Lafayette Pereira, Nicole Ferrari de Carvalho, Luiza Aparecida Luna Silvério, Ygor Jessé Ramos, Priscila Gava Mazzola\",\"doi\":\"10.3390/pharmacy12040100\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Although preliminary evidence suggests <i>Cannabis</i>'s efficacy in symptom control for anxiety and depression-psychiatric disorders that significantly impact mental health-much remains to be understood about its effects on the central nervous system (CNS) and how to optimize treatment for these disorders. This study aims to conduct a narrative review to evaluate pharmaceutical care in treating symptoms of anxiety and depression alongside <i>Cannabis</i> use, focusing on safety and therapeutic efficacy optimization. We seek to conceptualize anxiety and depression disorders, review evidence on <i>Cannabis</i> use, evaluate the evidence quality, and identify knowledge gaps. Twelve articles were identified, revealing a significant gap in the literature regarding the integration of pharmaceutical care with <i>Cannabis</i>-based therapies, specifically for anxiety and depression. Despite a growing interest in the relationship between <i>Cannabis</i> and mental health, current research is insufficient for a comprehensive understanding. The relationship between <i>Cannabis</i> use and anxiety and depression disorders requires further, more targeted investigations. This study underscores the importance of future research to fill existing gaps, providing informed insights and robust guidelines for the safe and effective use of <i>Cannabis</i> as part of the treatment for anxiety and depression. It is crucial that pharmaceutical care integrates these therapies responsibly to improve the overall well-being of patients.</p>\",\"PeriodicalId\":30544,\"journal\":{\"name\":\"Pharmacy\",\"volume\":\"12 4\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270281/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/pharmacy12040100\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pharmacy12040100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

尽管初步证据表明大麻对焦虑症和抑郁症(严重影响心理健康的精神疾病)的症状控制有一定疗效,但大麻对中枢神经系统(CNS)的影响以及如何优化这些疾病的治疗仍有许多问题有待了解。本研究旨在进行叙述性综述,评估在使用大麻的同时治疗焦虑和抑郁症状的药物护理,重点关注安全性和疗效优化。我们试图对焦虑症和抑郁症进行概念化,回顾有关使用大麻的证据,评估证据质量,并找出知识差距。我们发现了 12 篇文章,揭示了文献中关于药物治疗与大麻疗法(尤其是焦虑症和抑郁症)相结合的重大空白。尽管人们对大麻与心理健康之间的关系越来越感兴趣,但目前的研究还不足以让人们对其有一个全面的了解。对于使用大麻与焦虑症和抑郁症之间的关系,还需要进行更深入、更有针对性的调查。这项研究强调了未来研究填补现有空白的重要性,为安全有效地使用大麻作为焦虑症和抑郁症治疗的一部分提供了明智的见解和有力的指导。至关重要的是,药物治疗应负责任地整合这些疗法,以改善患者的整体福祉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis.

Although preliminary evidence suggests Cannabis's efficacy in symptom control for anxiety and depression-psychiatric disorders that significantly impact mental health-much remains to be understood about its effects on the central nervous system (CNS) and how to optimize treatment for these disorders. This study aims to conduct a narrative review to evaluate pharmaceutical care in treating symptoms of anxiety and depression alongside Cannabis use, focusing on safety and therapeutic efficacy optimization. We seek to conceptualize anxiety and depression disorders, review evidence on Cannabis use, evaluate the evidence quality, and identify knowledge gaps. Twelve articles were identified, revealing a significant gap in the literature regarding the integration of pharmaceutical care with Cannabis-based therapies, specifically for anxiety and depression. Despite a growing interest in the relationship between Cannabis and mental health, current research is insufficient for a comprehensive understanding. The relationship between Cannabis use and anxiety and depression disorders requires further, more targeted investigations. This study underscores the importance of future research to fill existing gaps, providing informed insights and robust guidelines for the safe and effective use of Cannabis as part of the treatment for anxiety and depression. It is crucial that pharmaceutical care integrates these therapies responsibly to improve the overall well-being of patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmacy
Pharmacy PHARMACOLOGY & PHARMACY-
自引率
9.10%
发文量
141
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信